Connect with us

Hi, what are you looking for?

Business

Philip Morris Buys Inhaled-Medicine Company for $1.2 Billion Amid Health Push

Philip Morris Buys Inhaled-Medicine Company for .2 Billion Amid Health Push

Philip Morris International Inc. agreed to buy Vectura Group PLC, a U.K. pharmaceuticals business specializing in inhaled medicines, for $1.24 billion in cash, bolstering its push to expand beyond tobacco and nicotine.

Philip Morris International, which is listed in New York but sells the Marlboro brand outside the U.S., on Friday said that Vectura will be the backbone of a business built around inhaled therapeutics. Inhalers used by asthma sufferers, for instance, are common for the treatment of respiratory illness, but have shown promise in the delivery of other medicines.

The deal trumps an earlier agreement in May by Vectura to be bought by Carlyle Group Inc. Philip Morris’s offer of 899.2 million poundsvalues Vectura at 150 pence a share, 10% higher than the private-equity firm’s bid. Carlyle said Friday it is considering its options.

Shares in Vectura were trading 13% higher in London.

Philip Morris said the acquisition is part of its evolution into a broader healthcare and wellness company. Earlier this year, it outlined plans to generate more than half of its revenue from smokeless products by 2025, up from 24% in 2020.

You May Also Like

World

France, which has opened its borders to Canadian tourists, is eager to see Canada reopen to the French. The Canadian border remains closed...

Health

Kashechewan First Nation in northern Ontario is experiencing a “deepening state of emergency” as a result of surging COVID-19 cases in the community...

World

The virus that causes COVID-19 could have started spreading in China as early as October 2019, two months before the first case was identified in the central city of Wuhan, a new study...

World

April Ross and Alix Klineman won the first Olympic gold medal for the United States in women’s beach volleyball since 2012 on Friday,...